Process for preparing 3,3-dimethylindolines
    41.
    发明授权
    Process for preparing 3,3-dimethylindolines 失效
    制备3,3-二甲基吲哚的方法

    公开(公告)号:US07687643B2

    公开(公告)日:2010-03-30

    申请号:US11014184

    申请日:2004-12-15

    IPC分类号: C07D209/40

    摘要: Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

    摘要翻译: 选择的胺对于预防和治疗疾病如血管生成介导的疾病是有效的。 本发明包括新颖的化合物,类似物,前药和药学上可接受的盐,用于预防和治疗疾病和其它疾病或涉及癌症等的病症的药物组合物和方法。 本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。

    Substituted pyridone compounds and methods of use
    43.
    发明申请
    Substituted pyridone compounds and methods of use 失效
    取代的吡啶酮化合物和使用方法

    公开(公告)号:US20080249090A1

    公开(公告)日:2008-10-09

    申请号:US11879830

    申请日:2007-07-18

    CPC分类号: C07D471/04 C07D401/04

    摘要: The present invention comprises a new class of compounds capable of modulating the c-kit receptor and, accordingly, useful for treatment of c-kit mediated diseases, including various inflammatory, fibrotic and/or mast cell mediated diseases such as mastocytosis. The compounds have a general Formula I wherein A0-3 and R1-6 are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of c-kit mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.

    摘要翻译: 本发明包括能够调节c-kit受体的新一类化合物,因此可用于治疗c-kit介导的疾病,包括各种炎性,纤维化和/或肥大细胞介导的疾病如肥大细胞增多症。 这些化合物具有通式I,其中A 0-3和R 6-16在本文中定义。 本发明还包括药物组合物,用于治疗c-kit介导的疾病的方法,以及可用于制备本发明化合物的中间体和方法。

    Compounds and methods of use
    44.
    发明申请
    Compounds and methods of use 失效
    化合物和使用方法

    公开(公告)号:US20080161346A1

    公开(公告)日:2008-07-03

    申请号:US12004156

    申请日:2007-12-19

    摘要: Selected compounds are effective for prophylaxis and treatment of diseases, such as VEGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

    摘要翻译: 选择的化合物对于预防和治疗诸如VEGF介导的疾病的疾病是有效的。 本发明包括新颖的化合物,类似物,前药和药学上可接受的盐,用于预防和治疗疾病和其它疾病或涉及癌症等的病症的药物组合物和方法。 本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。

    Substituted pyridone compounds and methods of use
    48.
    发明授权
    Substituted pyridone compounds and methods of use 失效
    取代的吡啶酮化合物和使用方法

    公开(公告)号:US08063055B2

    公开(公告)日:2011-11-22

    申请号:US12711167

    申请日:2010-02-23

    IPC分类号: A61K31/517

    CPC分类号: C07D471/04 C07D401/04

    摘要: The present invention comprises a new class of compounds capable of modulating the c-kit receptor and, accordingly, useful for treatment of c-kit mediated diseases, including various inflammatory, fibrotic and/or mast cell mediated diseases such as mastocytosis. The compounds have a general Formula I wherein A0-3 and R1-6 are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of c-kit mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.

    摘要翻译: 本发明包括能够调节c-kit受体的新一类化合物,因此可用于治疗c-kit介导的疾病,包括各种炎性,纤维化和/或肥大细胞介导的疾病如肥大细胞增多症。 化合物具有通式I,其中A0-3和R1-6在本文中定义。 本发明还包括药物组合物,用于治疗c-kit介导的疾病的方法,以及可用于制备本发明化合物的中间体和方法。

    Thieno-[2,3-d]Pyrimidine and Thieno-Pyridazine Compounds and Methods of Use
    49.
    发明申请
    Thieno-[2,3-d]Pyrimidine and Thieno-Pyridazine Compounds and Methods of Use 失效
    噻吩并[2,3-d]嘧啶和噻吩并哒嗪化合物及其使用方法

    公开(公告)号:US20100125074A1

    公开(公告)日:2010-05-20

    申请号:US12616646

    申请日:2009-11-11

    CPC分类号: C07D495/04

    摘要: The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation and related conditions. The compounds have a general Formula I wherein A1, A2, B, R2 and R3 are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, uses of such compounds and compositions for treatment of kinase mediated diseases including rheumatoid arthritis, psoriasis and other inflammation disorders, as well as intermediates and processes useful for the preparation of compounds of Formula I.

    摘要翻译: 本发明包括一类新的可用于预防和治疗蛋白激酶介导的疾病,包括炎症和相关病症的化合物。 该化合物具有通式I,其中A1,A2,B,R2和R3在本文中定义。 本发明还包括药物组合物,其包含一种或多种式I化合物,这些化合物和组合物用于治疗激酶介导的疾病包括类风湿性关节炎,牛皮癣和其它炎症疾病的用途,以及可用于制备 一级方程式